AIT THERAPEUTICS INC Chart calendar AIT Therapeutics Inc
42f0f9cc9bb136577cf3ca1.tsoWKXI6WtnTm5_cMuJo63sezVpkLGDZc4yCrD_ISQs.m6B0QgZTCe2l6cuPSokqjhUumQkmeAyVEeP7712eBjvXs3wfNH4cu4DE0g~bf5c123e856941d1b56614d109240aca
Upcoming events on AIT Therapeutics Inc
Past events on AIT Therapeutics Inc
| 07/03/2024 | Annual General Meeting |
| 12/02/2024 21:30 | Q3 2024 Earnings Call |
| 12/02/2024 21:05 | Q3 2024 Earnings Release |
| 30/11/2023 17:30 | Piper Sandler Healthcare Conference - Fireside Chat |
| 13/11/2023 21:30 | Q2 2024 Earnings Call |
| 13/11/2023 21:05 | Q2 2024 Earnings Release |
| 07/11/2023 | Beyond Air Company Presentation |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 733 |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No.: C080 |
| 12/10/2023 17:30 | AACR-NCI-EORTC International Conference - Poster No.: A078 |
| 11/10/2023 | Roth Healtcare Opportunities Conference |
| 27/09/2023 14:10 | Cantor Global Healthcare Conference |
| 10/08/2023 21:30 | Q1 2024 Earnings Call |
| 10/08/2023 21:05 | Q1 2024 Earnings Release |
| 06/08/2023 | BTIG Biotechnology Conference |
| 22/06/2023 21:30 | Q4 2023 Earnings Call |
| 22/06/2023 21:05 | Q4 2023 Earnings Release |
| 15/06/2023 21:30 | Business Update Call |
| 19/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract Number: 6327 |
| 19/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract Number: 6363 |
Annual results
| Fiscal Period | März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,72 6,63 16.59% | 1,39 2,00 -30.58% | 0,87 0,97 -9.57% | 0,00 0,00 - | 0,00 0,56 - | 1,44 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -22,0 -22,4 1.77% | -40,4 -26,8 -50.73% | -51,4 -52,4 1.86% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,06 -2,29 -33.39% | -18,1 -17,7 -2.63% | -22,2 -23,1 3.87% | -40,7 -28,2 -44.21% | -52,1 -52,6 1.09% | -67,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -6,00 -78.95% | -20,1 -19,6 -2.66% | -22,9 -23,6 3.02% | -44,1 -31,2 -41.38% | -59,4 -51,8 -14.72% | -66,3 |
|
Net income Million USD | Released Forecast Spread | -10,7 -6,00 -78.95% | -20,5 -19,7 -3.85% | -22,9 -23,6 3.02% | -43,2 -31,0 -39.48% | -55,8 -50,0 -11.58% | -62,5 |
|
EPS USD | Released Forecast Spread | -1,26 -0,27 -366.67% | -1,78 -1,79 0.7% | -1,27 -1,33 4.8% | -1,68 -1,21 -38.61% | -1,86 -1,66 -12.05% | -1,93 |
| Announcement Date | 25/06/19 | 23/06/20 | 10/06/21 | 29/06/22 | 22/06/23 | - |
Quarterly results
| Fiscal Period | März | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,56 - | 0,06 0,12 -49.14% | 0,24 0,48 -50.36% | 0,39 0,45 -12.96% | 0,75 | 1,61 | 2,53 | 3,80 | 5,07 |
|
EBITDA Million USD | Released Forecast Spread | -7,42 -6,20 -19.61% | -20,3 -6,70 -203.13% | -11,3 -9,10 -24.38% | -12,5 -10,9 -14.74% | -13,8 -14,7 6.16% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -7,49 -6,55 -14.3% | -20,4 -7,95 -157.06% | -11,4 -9,57 -19.58% | -12,6 -11,5 -9.51% | -14,0 -12,6 -10.89% | -14,0 -14,6 3.99% | -15,9 -14,9 -6.24% | -17,5 -15,3 -14.85% | -17,0 -17,5 3.24% | -16,8 | -16,1 | -15,7 | -15,9 | -15,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,96 -6,60 -20.73% | -20,7 -7,88 -162.28% | -11,7 -9,27 -25.76% | -12,8 -11,4 -11.77% | -13,8 -12,3 -12.14% | -21,2 -14,4 -46.53% | -15,1 -12,8 -17.54% | -17,4 -15,2 -14.92% | -17,3 -17,8 2.79% | -17,2 | -16,6 | -16,6 | -16,8 | -16,4 |
|
Net income Million USD | Released Forecast Spread | -7,74 -6,60 -17.35% | -20,0 -7,80 -156.51% | -10,9 -8,93 -22.4% | -12,0 -11,2 -6.78% | -12,7 -12,3 -3.5% | -20,2 -13,9 -44.97% | -14,1 -12,8 -10.05% | -16,2 -14,5 -12.12% | -16,2 -17,1 5.11% | -16,0 | -15,4 | -15,5 | -14,8 | -14,6 |
|
EPS USD | Released Forecast Spread | -0,29 -0,26 -11.54% | -0,73 -0,27 -174.44% | -0,37 -0,30 -24.72% | -0,40 -0,37 -8.11% | -0,43 -0,41 -5.74% | -0,67 -0,47 -43.06% | -0,45 -0,41 -11.11% | -0,51 -0,46 -11.35% | -0,50 -0,54 7.41% | -0,47 | -0,44 | -0,43 | -0,39 | -0,36 |
| Announcement Date | 10/02/22 | 29/06/22 | 11/08/22 | 08/11/22 | 10/02/23 | 22/06/23 | 15/08/23 | 13/11/23 | 12/02/24 | - | - | - | - | - |
| 05/05/2024 | TAIDOC TECHNOLOGY CORPORATION: Q1 2024 Earnings Release (Projected) |
| 05/05/2024 | ATRION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 11:00 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 06/05/2024 12:00 | AMPLIFON S.P.A.: Q1 2024 Earnings Release |
| 06/05/2024 21:05 | RXSIGHT, INC.: Q1 2024 Earnings Release |
| 06/05/2024 21:05 | ARTIVION, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | GLOBUS MEDICAL, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | AGILITI, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | ADAPTHEALTH CORP.: Q1 2024 Earnings Release |
| 06/05/2024 | ALPHATEC HOLDINGS, INC.: Q1 2024 Earnings Release |
Past sector events for AIT Therapeutics Inc
| 02/05/2024 21:05 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:15 | BAXTER INTERNATIONAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AVANOS MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | TELEFLEX INCORPORATED: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | ZIMMER BIOMET HOLDINGS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | BECTON, DICKINSON AND COMPANY: Q2 2024 Earnings Release |
| 02/05/2024 11:00 | DENTSPLY SIRONA INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:10 | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 21:01 | ATRICURE, INC.: Q1 2024 Earnings Release |
| 01/05/2024 14:00 | UFP TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
